70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast CancerFátima Cardoso, Martine Piccart, Laura J. van’t Veer et al.|New England Journal of Medicine|2016Cited by 2k
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trialSherene Loi, Christos Sotiriou, Pirkko Kellokumpu‐Lehtinen et al.|Annals of Oncology|2014Cited by 1.3k
The 2019 World Health Organization classification of tumours of the breastPuay Hoon Tan, Ian O. Ellis, Kimberly H. Allison et al.|Histopathology|2020Cited by 1.1k
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifenSherene Loi, Christos Sotiriou, Benjamin Haibe‐Kains et al.|BMC Genomics|2008Cited by 406
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by ageMartine Piccart, Emiel J. Rutgers, Laura van ‘t Veer et al.|The Lancet Oncology|2021Cited by 355